首页|中医药治疗幽门螺杆菌感染性慢性胃炎研究进展

中医药治疗幽门螺杆菌感染性慢性胃炎研究进展

扫码查看
中医学认为幽门螺杆菌(helicobacter pylori,Hp)感染性慢性胃炎(以下简称Hp胃炎)的基本病机是脾胃虚弱为本,湿邪阻滞为标.中医药治疗Hp胃炎的实验研究包括抗Hp的机制、单药和复方研究,临床研究包括抗Hp的中药复方、中成药和联合疗法研究.目前的研究存在以下问题:(1)中医辨证证型及疗效评估标准尚未完全统一,导致研究结论缺乏说服力;(2)治疗方法多为医家自拟方药或经验总结,难以形成统一、确切的诊疗标准;(3)现有研究多为临床对照试验,存在样本量小、随机对照不严格等弊端;(4)缺少高质量的动物实验和细胞实验,且存在菌株选择、实验方法混乱等问题.未来的研究可考虑:(1)继续开展多中心、大样本、高质量的临床研究;(2)严格设计动物实验和细胞实验,并需提前确立实验标准;(3)在复方研究的同时,完善中药活性成分提取及分析,进一步明确中药的药理机制.
Research Progress of TCM in the Treatment of Helicobacter Pylori-infected Chronic Gastritis
According to TCM,the basic pathogenesis of Helicobacter pylori(Hp)-infected chronic gastritis(hereinafter referred to as Hp gastritis)is spleen-stomach as the root cause and dampness blockage as the manifestation.Experimental research on the treatment of Hp gastritis by TCM includes the mechanism,single drug and compound drug research,while clinical research includes anti-Hp classi-cal formulas,patent Chinese medicine and combined therapy research.The current research has the following problems:(1)The syn-drome differentiation and therapeutic evaluation standards of TCM are not completely unified,which leads to the lack of convincing con-clusions.(2)Most of the reported treatment methods are self-made formulas or experience summaries,which are difficult to form a uni-fied and exact standard of diagnosis and treatment.(3)Most of the existing research is about clinical control trials,which has the disad-vantages of small sample size and loose random comparison.(4)There is lack of high-quality animal experiments and cell experiments,and there are problems such as strain selection and experimental method confusion.So the future research should consider the following:(1)To continue to carry out multi-center,large-sample,high-quality clinical research.(2)To Strictly design animal experiments and cell experiments,and establish experimental standards in advance.(3)Besides compound drug research,to perfect the extraction and a-nalysis of active ingredients of Chinese drugs,and further clarify the pharmacological mechanism of Chinese drugs.

Helicobacter pylori(Hp)chronic gastritisclassical formulasChinese patent medicinecombined therapy

陈涛、薛春丽、张菡、张士金

展开 >

河南中医药大学人民医院,河南郑州 450003

幽门螺杆菌 慢性胃炎 经方 中成药 联合疗法

河南省医学科技攻关计划联合共建项目

LHGJ20220776

2024

河南中医
河南省中医药学会 河南中医学院

河南中医

影响因子:0.968
ISSN:1003-5028
年,卷(期):2024.44(2)
  • 69